BioSpace News Archive

In a groundbreaking development for the Middle East, King Faisal Specialist Hospital and Research Centre has introduced a service called Rapid Whole-Genome Sequencing (rWGS) as part of its healthcare solutions.

iCAD, Inc. today announced that it will release financial results for the third quarter ended September 30, 2023, after the market close, and host a conference call at 4:30 PM Eastern Time on Monday, November 13, 2023.

MiNK Therapeutics, Inc. announced that the company will release its third quarter 2023 financial results via press release before the market opens on Thursday, Nov. 9, 2023.

Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) for tovorafenib as a monotherapy in relapsed or progressive pediatric low-grade glioma (pLGG).

BioVie Inc. today announced that the Company’s management will host a conference call and webcast on Wednesday, November 1 2023 at 8:00 AM Eastern Time.

SeaStar Medical Holding Corporation (Nasdaq: ICU) announces that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has issued an Approvable Letter for the company’s proprietary Selective Cytopheretic Device Pediatric (SCD-PED) for use in children weighing 10 kilograms or more with acute kidney injury (AKI) and sepsis or a septic condition requiring continuous kidney replacement therapy (CKRT) in the hospital intensive care unit (ICU).

CytomX Therapeutics, Inc. today announced that preclinical data supporting CX-801, its conditionally activated cytokine program, will be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting in San Diego, California.

Triumvira Immunologics today announced that it will participate with one oral presentation and four posters at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting in San Diego, California, from November 1-5.

Ceribell, Inc.® announced the commercial release of its new AI algorithm, ClarityPro™, accompanying the availability of potential additional reimbursement for eligible Medicare patients.

IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure” or the “Company”) today announced its participation in the 10th Annual Conference of the Breast Imaging Society of India (BISICON 2023) in conjunction with its in-country distributor, Novomed, from October 27-29, 2023.